Opendata, web and dolomites
H2020 projects about "blindness"
The page lists 53 projects related to the topic "blindness".
| # | |||
|---|---|---|---|
| 1 | EyeRegen | Engineering a scaffold based therapy for corneal regeneration | 2015 |
| 2 | PRO4VIP | Innovative PROcurement for Visual Impaired People | 2015 |
| 3 | DANCE | Dancing in the Dark | 2015 |
| 4 | NiGlucoMon | A Non-Invasive GLUCOse MONitoring device for diabetics based on Stimulated Raman Spectroscopy in a quick, cheap and painless method. | 2014 |
| 5 | InSIght | Information from Symbols and Illustrations: how to get it without vision | 2015 |
| 6 | EGRET | European Glaucoma Research Training Program | 2015 |
| 7 | STROBE | Sustained Release Ocular Bevacizumab for the treatment of wet acute macular degeneration | 2015 |
| 8 | Spectra | Spectra- A novel diagnostic device to improve retinal imaging | 2015 |
| 9 | EGRET-Plus | European Glaucoma Research Training Program-Plus | 2016 |
| 10 | MYOP-PATH | Towards solving myopia: from genes to pathways using an integrated approach | 2015 |
| 11 | RETMUS | The interpretation of retinal activity by the visual thalamus. | 2015 |
| 12 | OCTCHIP | Ophthalmic OCT on a Chip | 2016 |
| 13 | ARREST BLINDNESS | Advanced Regenerative and REStorative Therapies to combat corneal BLINDNESS | 2016 |
| 14 | QUMAG | QUANTUM OPTICAL MAGNETOMETER FOR MEDICAL APPLICATIONS | 2016 |
| 15 | COcOAB | Characterizing the Occipital Oscillatory Activity in Blindness | 2016 |
| 16 | TACT | Towards an objective and quantitative Assessment of human Corneal Transparency | 2017 |
| 17 | iRELaTE | Immune Response and Social Cognition in Schizophrenia | 2016 |
| 18 | EYEGET | Gene therapy of inherited retinal diseases | 2017 |
| 19 | ProEmpower | Procuring innovative ICT for patient empowerment and self-management for type 2 diabetes mellitus | 2016 |
| 20 | GLAUrious | External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation | 2016 |
| 21 | GALAHAD | Glaucoma – Advanced, LAbel-free High resolution Automated OCT Diagnostics | 2016 |
| 22 | AMPK-DIAB | A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes | 2016 |
| 23 | EyeSynth | Audio-Visual System for the Blind Allowing Visually Impaired to See Through Hearing | 2017 |
| 24 | ENCOGLAP | ENvironmental COnditions in GLAucoma Patients | 2017 |
| 25 | EXO-EYE | Stem Cell-Derived Exosomes for the treatment of Traumatic and Degenerative Eye Disease | 2017 |
| 26 | Smartscope-X | Affordable, accessible and automatic screening solution for diabetic retinopathy | 2017 |
| 27 | EVA | SMART CITY NAVIGATION TOOL FOR THE VISUALLY IMPAIRED | 2017 |
| 28 | MACULA2 | Commercialising a novel diagnostic panel for patient stratification in Age-related MACULAr Degeneration | 2017 |
| 29 | EUROMIX | Regulating mixed intimacies in Europe | 2017 |
| 30 | UshTher | Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB | 2018 |
| 31 | Soraprazan | Soraprazan - a new regenerative therapy for Stargardt's disease | 2017 |
| 32 | MERLIN | Multi-modal, multi-scale retinal imaging | 2017 |
| 33 | PAMpeR | Patroller monocytes as modulators of diabetic retinopathy | 2018 |
| 34 | EUROVISION | Self-reported vision status and associated risk factors in Europe: prevalence and temporal change | 2018 |
| 35 | LIGHTUP | Turning the cortically blind brain to see: from neural computations to system dynamicsgenerating visual awareness in humans and monkeys | 2018 |
| 36 | PanINSULA | PanINSULA - The next first commercially sustainable and therapeutically effective beta cell therapy for diabetes | 2018 |
| 37 | Me-Check | Me-Check - Screening of the dry eye syndrome | 2019 |
| 38 | BIEL SMARTGAZE | Electronic glasses which use computer vision and augmented reality to improve visual capacity and increase autonomy of people who have low vision | 2019 |
| 39 | D2P | Diabeloop to Patients: An Artificial Pancreas solution to improve the balance, safety and autonomy of 20 million people | 2019 |
| 40 | ORBITAL | Ocular Research By Integrated Training And Learning | 2019 |
| 41 | inSight | Moving a novel gene therapy paradigm to treat blindness to the market | 2019 |
| 42 | RODRESET | Development of novel optogenetic approaches for improving vision in macular degeneration | 2019 |
| 43 | RetinDR | RetinDR: The first topical ophthalmic formulation (eye drops) that effectively prevents and/or treats the retinal neurodegeneration induced by diabetes (diabetic retinopathy) and/or aging | 2019 |
| 44 | ISSO | Innovative Swept Source for next generation OCT devices | 2019 |
| 45 | INSIGHT EU | INSIGHT FOR EYESIGHT – Novel mRNA medicines for eye disease | 2019 |
| 46 | TRS | A paradigm change in the treatment of blinding ocular diseases | 2019 |
| 47 | SA-VOIR | Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action | 2019 |
| 48 | aiVision | Innovative AI-based Ophthalmologic Diagnosis | 2019 |
| 49 | SIROCO | Sparing gene therapy for Inherited ROd COne dystrophies | 2019 |
| 50 | BlueDot | A long-acting, constant release ocular implant for the sustained delivery of biologics and small molecules for the treatment of retinal diseases. | 2019 |
| 51 | Savesight | Contact lens embedded sensor for ocular hypertension and glaucoma monitoring | 2020 |
| 52 | iScan | Automated retinal scans for early detection of diabetic eye diseases through use of artificial intelligence | 2020 |
| 53 | EIS | An innovative, effective and minimally-invasive retinal cell therapy combined with a new injection system for treatment of retinal degenerative diseases. | 2019 |